House Committee on Health Chairperson Angelina Tan seeks to re-open the investigation regarding the effects of Dengvaxia to Filipinos following the announcement of the World Health Organization that they did not endorse the use of the said anti-dengue vaccine in the Philippines.
Sanofi Pasteur, manufacturer of Dengvaxia, also admitted that the said vaccine is dangerous for individuals who have not been hit by the dengue virus.
Tan said that they already have a recommendation after the committee investigated the issue in 2016, but it was not released to the plenary.
Other than the House Committee on Health, the House Committee on Good Government is also looking on the anomalies in the procurement of Php 3.5 billion worth of Dengvaxia.
“Nag-hearing ang Committee on Good Government and Committee on Health, and in fact nag-terminate na kami.” Tan told DZRH. “Yung Committee report lang ang waiting. And since new development, I requested for the re-opening.”